Medicare negotiating drug prices will likely save the U.S. billions, study says

A provision in the Inflation Reduction Act that allows Medicare to negotiate prices on the costliest prescription drugs each year will likely save the U.S. billions of dollars — as long as the drug industry doesn't interfere, according to a study published Friday in JAMA Health Forum. Beginning in 2026, Medicare will begin negotiating the price of 10 drugs that cost the federal government the most money, followed by 15 more drugs in 2027, another 15 drugs in 2028, and another 20 drugs in each subsequent year.
Read more: https://www.nbcnews.com/health/health-news/medicare-negotiating-drug-prices-will-likely-us-billions-study-says-rcna67820?source=Snapzu